Global Streptococcus Pneumoniae Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Streptococcus Pneumoniae Vaccine Industry Forecast” looks at past sales and reviews total world Streptococcus Pneumoniae Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Streptococcus Pneumoniae Vaccine sales for 2023 through 2029. With Streptococcus Pneumoniae Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Streptococcus Pneumoniae Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Streptococcus Pneumoniae Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Streptococcus Pneumoniae Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Streptococcus Pneumoniae Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Streptococcus Pneumoniae Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Streptococcus Pneumoniae Vaccine.
The global Streptococcus Pneumoniae Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Streptococcus Pneumoniae Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Streptococcus Pneumoniae Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Streptococcus Pneumoniae Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Streptococcus Pneumoniae Vaccine players cover Pfizer, Sanofi, GSK, Merck, Eli Lilly, AstraZeneca, Abera, S K Chemicals and Beijing Minhai Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Pneumoniae Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Streptococcus Pneumoniae Vaccine market?
What factors are driving Streptococcus Pneumoniae Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Streptococcus Pneumoniae Vaccine market opportunities vary by end market size?
How does Streptococcus Pneumoniae Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Streptococcus Pneumoniae Vaccine Industry Forecast” looks at past sales and reviews total world Streptococcus Pneumoniae Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Streptococcus Pneumoniae Vaccine sales for 2023 through 2029. With Streptococcus Pneumoniae Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Streptococcus Pneumoniae Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Streptococcus Pneumoniae Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Streptococcus Pneumoniae Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Streptococcus Pneumoniae Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Streptococcus Pneumoniae Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Streptococcus Pneumoniae Vaccine.
The global Streptococcus Pneumoniae Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Streptococcus Pneumoniae Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Streptococcus Pneumoniae Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Streptococcus Pneumoniae Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Streptococcus Pneumoniae Vaccine players cover Pfizer, Sanofi, GSK, Merck, Eli Lilly, AstraZeneca, Abera, S K Chemicals and Beijing Minhai Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Pneumoniae Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 7 -Valent
- 10 -Valent
- 13 -Valent
- 15 -Valent
- 23 -Valent
- Other
- Children under 2 Years of Age
- Adults over 65 Years of Age
- Addicted Smokers Between the Ages of 19 and 64
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Sanofi
- GSK
- Merck
- Eli Lilly
- AstraZeneca
- Abera
- S K Chemicals
- Beijing Minhai Biotechnology
- Baxter
- Biken
- Celgene Corporation
- Panacea Biotec
- Serum Institute of India
- Genentech
- Genocea Biosciences
- ImmunoBiology
- Lupin
- Nuron Biotech
- Biogen
- Valneva Austria
- Sinovac
What is the 10-year outlook for the global Streptococcus Pneumoniae Vaccine market?
What factors are driving Streptococcus Pneumoniae Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Streptococcus Pneumoniae Vaccine market opportunities vary by end market size?
How does Streptococcus Pneumoniae Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Streptococcus Pneumoniae Vaccine Segment by Type
2.2.1 7 -Valent
2.2.2 10 -Valent
2.2.3 13 -Valent
2.2.4 15 -Valent
2.2.5 23 -Valent
2.2.6 Other
2.3 Streptococcus Pneumoniae Vaccine Sales by Type
2.3.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2018-2023)
2.4 Streptococcus Pneumoniae Vaccine Segment by Application
2.4.1 Children under 2 Years of Age
2.4.2 Adults over 65 Years of Age
2.4.3 Addicted Smokers Between the Ages of 19 and
2.4.4 Other
2.5 Streptococcus Pneumoniae Vaccine Sales by Application
2.5.1 Global Streptococcus Pneumoniae Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2018-2023)
3 GLOBAL STREPTOCOCCUS PNEUMONIAE VACCINE BY COMPANY
3.1 Global Streptococcus Pneumoniae Vaccine Breakdown Data by Company
3.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Streptococcus Pneumoniae Vaccine Revenue by Company (2018-2023)
3.2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Company
3.4 Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Streptococcus Pneumoniae Vaccine Product Location Distribution
3.4.2 Players Streptococcus Pneumoniae Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR STREPTOCOCCUS PNEUMONIAE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Streptococcus Pneumoniae Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Streptococcus Pneumoniae Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Streptococcus Pneumoniae Vaccine Sales Growth
4.4 APAC Streptococcus Pneumoniae Vaccine Sales Growth
4.5 Europe Streptococcus Pneumoniae Vaccine Sales Growth
4.6 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Growth
5 AMERICAS
5.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country
5.1.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023)
5.1.2 Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023)
5.2 Americas Streptococcus Pneumoniae Vaccine Sales by Type
5.3 Americas Streptococcus Pneumoniae Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region
6.1.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region (2018-2023)
6.1.2 APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2018-2023)
6.2 APAC Streptococcus Pneumoniae Vaccine Sales by Type
6.3 APAC Streptococcus Pneumoniae Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Streptococcus Pneumoniae Vaccine by Country
7.1.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023)
7.1.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023)
7.2 Europe Streptococcus Pneumoniae Vaccine Sales by Type
7.3 Europe Streptococcus Pneumoniae Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Streptococcus Pneumoniae Vaccine by Country
8.1.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type
8.3 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine
10.3 Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
10.4 Industry Chain Structure of Streptococcus Pneumoniae Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Streptococcus Pneumoniae Vaccine Distributors
11.3 Streptococcus Pneumoniae Vaccine Customer
12 WORLD FORECAST REVIEW FOR STREPTOCOCCUS PNEUMONIAE VACCINE BY GEOGRAPHIC REGION
12.1 Global Streptococcus Pneumoniae Vaccine Market Size Forecast by Region
12.1.1 Global Streptococcus Pneumoniae Vaccine Forecast by Region (2024-2029)
12.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Streptococcus Pneumoniae Vaccine Forecast by Type
12.7 Global Streptococcus Pneumoniae Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 AstraZeneca
13.6.1 AstraZeneca Company Information
13.6.2 AstraZeneca Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AstraZeneca Main Business Overview
13.6.5 AstraZeneca Latest Developments
13.7 Abera
13.7.1 Abera Company Information
13.7.2 Abera Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.7.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abera Main Business Overview
13.7.5 Abera Latest Developments
13.8 S K Chemicals
13.8.1 S K Chemicals Company Information
13.8.2 S K Chemicals Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 S K Chemicals Main Business Overview
13.8.5 S K Chemicals Latest Developments
13.9 Beijing Minhai Biotechnology
13.9.1 Beijing Minhai Biotechnology Company Information
13.9.2 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Minhai Biotechnology Main Business Overview
13.9.5 Beijing Minhai Biotechnology Latest Developments
13.10 Baxter
13.10.1 Baxter Company Information
13.10.2 Baxter Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Baxter Main Business Overview
13.10.5 Baxter Latest Developments
13.11 Biken
13.11.1 Biken Company Information
13.11.2 Biken Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biken Main Business Overview
13.11.5 Biken Latest Developments
13.12 Celgene Corporation
13.12.1 Celgene Corporation Company Information
13.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Celgene Corporation Main Business Overview
13.12.5 Celgene Corporation Latest Developments
13.13 Panacea Biotec
13.13.1 Panacea Biotec Company Information
13.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Panacea Biotec Main Business Overview
13.13.5 Panacea Biotec Latest Developments
13.14 Serum Institute of India
13.14.1 Serum Institute of India Company Information
13.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Serum Institute of India Main Business Overview
13.14.5 Serum Institute of India Latest Developments
13.15 Genentech
13.15.1 Genentech Company Information
13.15.2 Genentech Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Genentech Main Business Overview
13.15.5 Genentech Latest Developments
13.16 Genocea Biosciences
13.16.1 Genocea Biosciences Company Information
13.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Genocea Biosciences Main Business Overview
13.16.5 Genocea Biosciences Latest Developments
13.17 ImmunoBiology
13.17.1 ImmunoBiology Company Information
13.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 ImmunoBiology Main Business Overview
13.17.5 ImmunoBiology Latest Developments
13.18 Lupin
13.18.1 Lupin Company Information
13.18.2 Lupin Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Lupin Main Business Overview
13.18.5 Lupin Latest Developments
13.19 Nuron Biotech
13.19.1 Nuron Biotech Company Information
13.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Nuron Biotech Main Business Overview
13.19.5 Nuron Biotech Latest Developments
13.20 Biogen
13.20.1 Biogen Company Information
13.20.2 Biogen Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Biogen Main Business Overview
13.20.5 Biogen Latest Developments
13.21 Valneva Austria
13.21.1 Valneva Austria Company Information
13.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Valneva Austria Main Business Overview
13.21.5 Valneva Austria Latest Developments
13.22 Sinovac
13.22.1 Sinovac Company Information
13.22.2 Sinovac Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Sinovac Main Business Overview
13.22.5 Sinovac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Streptococcus Pneumoniae Vaccine Segment by Type
2.2.1 7 -Valent
2.2.2 10 -Valent
2.2.3 13 -Valent
2.2.4 15 -Valent
2.2.5 23 -Valent
2.2.6 Other
2.3 Streptococcus Pneumoniae Vaccine Sales by Type
2.3.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2018-2023)
2.4 Streptococcus Pneumoniae Vaccine Segment by Application
2.4.1 Children under 2 Years of Age
2.4.2 Adults over 65 Years of Age
2.4.3 Addicted Smokers Between the Ages of 19 and
2.4.4 Other
2.5 Streptococcus Pneumoniae Vaccine Sales by Application
2.5.1 Global Streptococcus Pneumoniae Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2018-2023)
3 GLOBAL STREPTOCOCCUS PNEUMONIAE VACCINE BY COMPANY
3.1 Global Streptococcus Pneumoniae Vaccine Breakdown Data by Company
3.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Streptococcus Pneumoniae Vaccine Revenue by Company (2018-2023)
3.2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Company
3.4 Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Streptococcus Pneumoniae Vaccine Product Location Distribution
3.4.2 Players Streptococcus Pneumoniae Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR STREPTOCOCCUS PNEUMONIAE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Streptococcus Pneumoniae Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Streptococcus Pneumoniae Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Streptococcus Pneumoniae Vaccine Sales Growth
4.4 APAC Streptococcus Pneumoniae Vaccine Sales Growth
4.5 Europe Streptococcus Pneumoniae Vaccine Sales Growth
4.6 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Growth
5 AMERICAS
5.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country
5.1.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023)
5.1.2 Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023)
5.2 Americas Streptococcus Pneumoniae Vaccine Sales by Type
5.3 Americas Streptococcus Pneumoniae Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region
6.1.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region (2018-2023)
6.1.2 APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2018-2023)
6.2 APAC Streptococcus Pneumoniae Vaccine Sales by Type
6.3 APAC Streptococcus Pneumoniae Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Streptococcus Pneumoniae Vaccine by Country
7.1.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023)
7.1.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023)
7.2 Europe Streptococcus Pneumoniae Vaccine Sales by Type
7.3 Europe Streptococcus Pneumoniae Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Streptococcus Pneumoniae Vaccine by Country
8.1.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type
8.3 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine
10.3 Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
10.4 Industry Chain Structure of Streptococcus Pneumoniae Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Streptococcus Pneumoniae Vaccine Distributors
11.3 Streptococcus Pneumoniae Vaccine Customer
12 WORLD FORECAST REVIEW FOR STREPTOCOCCUS PNEUMONIAE VACCINE BY GEOGRAPHIC REGION
12.1 Global Streptococcus Pneumoniae Vaccine Market Size Forecast by Region
12.1.1 Global Streptococcus Pneumoniae Vaccine Forecast by Region (2024-2029)
12.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Streptococcus Pneumoniae Vaccine Forecast by Type
12.7 Global Streptococcus Pneumoniae Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 AstraZeneca
13.6.1 AstraZeneca Company Information
13.6.2 AstraZeneca Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AstraZeneca Main Business Overview
13.6.5 AstraZeneca Latest Developments
13.7 Abera
13.7.1 Abera Company Information
13.7.2 Abera Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.7.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abera Main Business Overview
13.7.5 Abera Latest Developments
13.8 S K Chemicals
13.8.1 S K Chemicals Company Information
13.8.2 S K Chemicals Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 S K Chemicals Main Business Overview
13.8.5 S K Chemicals Latest Developments
13.9 Beijing Minhai Biotechnology
13.9.1 Beijing Minhai Biotechnology Company Information
13.9.2 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Minhai Biotechnology Main Business Overview
13.9.5 Beijing Minhai Biotechnology Latest Developments
13.10 Baxter
13.10.1 Baxter Company Information
13.10.2 Baxter Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Baxter Main Business Overview
13.10.5 Baxter Latest Developments
13.11 Biken
13.11.1 Biken Company Information
13.11.2 Biken Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biken Main Business Overview
13.11.5 Biken Latest Developments
13.12 Celgene Corporation
13.12.1 Celgene Corporation Company Information
13.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Celgene Corporation Main Business Overview
13.12.5 Celgene Corporation Latest Developments
13.13 Panacea Biotec
13.13.1 Panacea Biotec Company Information
13.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Panacea Biotec Main Business Overview
13.13.5 Panacea Biotec Latest Developments
13.14 Serum Institute of India
13.14.1 Serum Institute of India Company Information
13.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Serum Institute of India Main Business Overview
13.14.5 Serum Institute of India Latest Developments
13.15 Genentech
13.15.1 Genentech Company Information
13.15.2 Genentech Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Genentech Main Business Overview
13.15.5 Genentech Latest Developments
13.16 Genocea Biosciences
13.16.1 Genocea Biosciences Company Information
13.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Genocea Biosciences Main Business Overview
13.16.5 Genocea Biosciences Latest Developments
13.17 ImmunoBiology
13.17.1 ImmunoBiology Company Information
13.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 ImmunoBiology Main Business Overview
13.17.5 ImmunoBiology Latest Developments
13.18 Lupin
13.18.1 Lupin Company Information
13.18.2 Lupin Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Lupin Main Business Overview
13.18.5 Lupin Latest Developments
13.19 Nuron Biotech
13.19.1 Nuron Biotech Company Information
13.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Nuron Biotech Main Business Overview
13.19.5 Nuron Biotech Latest Developments
13.20 Biogen
13.20.1 Biogen Company Information
13.20.2 Biogen Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Biogen Main Business Overview
13.20.5 Biogen Latest Developments
13.21 Valneva Austria
13.21.1 Valneva Austria Company Information
13.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Valneva Austria Main Business Overview
13.21.5 Valneva Austria Latest Developments
13.22 Sinovac
13.22.1 Sinovac Company Information
13.22.2 Sinovac Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
13.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Sinovac Main Business Overview
13.22.5 Sinovac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 7 -Valent
Table 4. Major Players of 10 -Valent
Table 5. Major Players of 13 -Valent
Table 6. Major Players of 15 -Valent
Table 7. Major Players of 23 -Valent
Table 8. Major Players of Other
Table 9. Global Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 10. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Table 11. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2018-2023) & ($ million)
Table 12. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2018-2023)
Table 13. Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Table 16. Global Streptococcus Pneumoniae Vaccine Revenue by Application (2018-2023)
Table 17. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2018-2023)
Table 18. Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Streptococcus Pneumoniae Vaccine Sales by Company (2018-2023) & (K Units)
Table 20. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2018-2023)
Table 21. Global Streptococcus Pneumoniae Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2018-2023)
Table 23. Global Streptococcus Pneumoniae Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution and Sales Area
Table 25. Players Streptococcus Pneumoniae Vaccine Products Offered
Table 26. Streptococcus Pneumoniae Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Streptococcus Pneumoniae Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Streptococcus Pneumoniae Vaccine Sales Market Share Geographic Region (2018-2023)
Table 31. Global Streptococcus Pneumoniae Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Streptococcus Pneumoniae Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Country/Region (2018-2023)
Table 35. Global Streptococcus Pneumoniae Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023) & (K Units)
Table 38. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2023)
Table 39. Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2023)
Table 41. Americas Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 42. Americas Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 43. APAC Streptococcus Pneumoniae Vaccine Sales by Region (2018-2023) & (K Units)
Table 44. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2018-2023)
Table 45. APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2018-2023)
Table 47. APAC Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 48. APAC Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 49. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023) & (K Units)
Table 50. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2023)
Table 51. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2023)
Table 53. Europe Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 54. Europe Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Streptococcus Pneumoniae Vaccine
Table 62. Key Market Challenges & Risks of Streptococcus Pneumoniae Vaccine
Table 63. Key Industry Trends of Streptococcus Pneumoniae Vaccine
Table 64. Streptococcus Pneumoniae Vaccine Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Streptococcus Pneumoniae Vaccine Distributors List
Table 67. Streptococcus Pneumoniae Vaccine Customer List
Table 68. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Pfizer Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 84. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Sanofi Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 89. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. GSK Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 94. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Merck Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 99. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Eli Lilly Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Eli Lilly Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 104. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Eli Lilly Main Business
Table 106. Eli Lilly Latest Developments
Table 107. AstraZeneca Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. AstraZeneca Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 109. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. AstraZeneca Main Business
Table 111. AstraZeneca Latest Developments
Table 112. Abera Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Abera Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 114. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Abera Main Business
Table 116. Abera Latest Developments
Table 117. S K Chemicals Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. S K Chemicals Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 119. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. S K Chemicals Main Business
Table 121. S K Chemicals Latest Developments
Table 122. Beijing Minhai Biotechnology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 124. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Beijing Minhai Biotechnology Main Business
Table 126. Beijing Minhai Biotechnology Latest Developments
Table 127. Baxter Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Baxter Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 129. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Baxter Main Business
Table 131. Baxter Latest Developments
Table 132. Biken Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Biken Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 134. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Biken Main Business
Table 136. Biken Latest Developments
Table 137. Celgene Corporation Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Celgene Corporation Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 139. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Celgene Corporation Main Business
Table 141. Celgene Corporation Latest Developments
Table 142. Panacea Biotec Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Panacea Biotec Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 144. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Panacea Biotec Main Business
Table 146. Panacea Biotec Latest Developments
Table 147. Serum Institute of India Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Serum Institute of India Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 149. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Serum Institute of India Main Business
Table 151. Serum Institute of India Latest Developments
Table 152. Genentech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Genentech Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 154. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. Genentech Main Business
Table 156. Genentech Latest Developments
Table 157. Genocea Biosciences Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 159. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. Genocea Biosciences Main Business
Table 161. Genocea Biosciences Latest Developments
Table 162. ImmunoBiology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. ImmunoBiology Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 164. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. ImmunoBiology Main Business
Table 166. ImmunoBiology Latest Developments
Table 167. Lupin Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 168. Lupin Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 169. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 170. Lupin Main Business
Table 171. Lupin Latest Developments
Table 172. Nuron Biotech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 173. Nuron Biotech Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 174. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 175. Nuron Biotech Main Business
Table 176. Nuron Biotech Latest Developments
Table 177. Biogen Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 178. Biogen Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 179. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 180. Biogen Main Business
Table 181. Biogen Latest Developments
Table 182. Valneva Austria Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 183. Valneva Austria Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 184. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 185. Valneva Austria Main Business
Table 186. Valneva Austria Latest Developments
Table 187. Sinovac Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 188. Sinovac Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 189. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 190. Sinovac Main Business
Table 191. Sinovac Latest Developments
Table 1. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 7 -Valent
Table 4. Major Players of 10 -Valent
Table 5. Major Players of 13 -Valent
Table 6. Major Players of 15 -Valent
Table 7. Major Players of 23 -Valent
Table 8. Major Players of Other
Table 9. Global Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 10. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Table 11. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2018-2023) & ($ million)
Table 12. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2018-2023)
Table 13. Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Table 16. Global Streptococcus Pneumoniae Vaccine Revenue by Application (2018-2023)
Table 17. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2018-2023)
Table 18. Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Streptococcus Pneumoniae Vaccine Sales by Company (2018-2023) & (K Units)
Table 20. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2018-2023)
Table 21. Global Streptococcus Pneumoniae Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2018-2023)
Table 23. Global Streptococcus Pneumoniae Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution and Sales Area
Table 25. Players Streptococcus Pneumoniae Vaccine Products Offered
Table 26. Streptococcus Pneumoniae Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Streptococcus Pneumoniae Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Streptococcus Pneumoniae Vaccine Sales Market Share Geographic Region (2018-2023)
Table 31. Global Streptococcus Pneumoniae Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Streptococcus Pneumoniae Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Country/Region (2018-2023)
Table 35. Global Streptococcus Pneumoniae Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023) & (K Units)
Table 38. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2023)
Table 39. Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2023)
Table 41. Americas Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 42. Americas Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 43. APAC Streptococcus Pneumoniae Vaccine Sales by Region (2018-2023) & (K Units)
Table 44. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2018-2023)
Table 45. APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2018-2023)
Table 47. APAC Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 48. APAC Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 49. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023) & (K Units)
Table 50. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2023)
Table 51. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2023)
Table 53. Europe Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 54. Europe Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Streptococcus Pneumoniae Vaccine
Table 62. Key Market Challenges & Risks of Streptococcus Pneumoniae Vaccine
Table 63. Key Industry Trends of Streptococcus Pneumoniae Vaccine
Table 64. Streptococcus Pneumoniae Vaccine Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Streptococcus Pneumoniae Vaccine Distributors List
Table 67. Streptococcus Pneumoniae Vaccine Customer List
Table 68. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Pfizer Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 84. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Sanofi Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 89. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. GSK Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. GSK Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 94. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. GSK Main Business
Table 96. GSK Latest Developments
Table 97. Merck Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 99. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Eli Lilly Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Eli Lilly Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 104. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Eli Lilly Main Business
Table 106. Eli Lilly Latest Developments
Table 107. AstraZeneca Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. AstraZeneca Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 109. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. AstraZeneca Main Business
Table 111. AstraZeneca Latest Developments
Table 112. Abera Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Abera Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 114. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Abera Main Business
Table 116. Abera Latest Developments
Table 117. S K Chemicals Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. S K Chemicals Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 119. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. S K Chemicals Main Business
Table 121. S K Chemicals Latest Developments
Table 122. Beijing Minhai Biotechnology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 124. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Beijing Minhai Biotechnology Main Business
Table 126. Beijing Minhai Biotechnology Latest Developments
Table 127. Baxter Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Baxter Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 129. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Baxter Main Business
Table 131. Baxter Latest Developments
Table 132. Biken Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Biken Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 134. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Biken Main Business
Table 136. Biken Latest Developments
Table 137. Celgene Corporation Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. Celgene Corporation Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 139. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Celgene Corporation Main Business
Table 141. Celgene Corporation Latest Developments
Table 142. Panacea Biotec Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Panacea Biotec Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 144. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Panacea Biotec Main Business
Table 146. Panacea Biotec Latest Developments
Table 147. Serum Institute of India Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 148. Serum Institute of India Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 149. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Serum Institute of India Main Business
Table 151. Serum Institute of India Latest Developments
Table 152. Genentech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 153. Genentech Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 154. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. Genentech Main Business
Table 156. Genentech Latest Developments
Table 157. Genocea Biosciences Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 158. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 159. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. Genocea Biosciences Main Business
Table 161. Genocea Biosciences Latest Developments
Table 162. ImmunoBiology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 163. ImmunoBiology Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 164. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. ImmunoBiology Main Business
Table 166. ImmunoBiology Latest Developments
Table 167. Lupin Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 168. Lupin Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 169. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 170. Lupin Main Business
Table 171. Lupin Latest Developments
Table 172. Nuron Biotech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 173. Nuron Biotech Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 174. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 175. Nuron Biotech Main Business
Table 176. Nuron Biotech Latest Developments
Table 177. Biogen Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 178. Biogen Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 179. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 180. Biogen Main Business
Table 181. Biogen Latest Developments
Table 182. Valneva Austria Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 183. Valneva Austria Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 184. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 185. Valneva Austria Main Business
Table 186. Valneva Austria Latest Developments
Table 187. Sinovac Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 188. Sinovac Streptococcus Pneumoniae Vaccine Product Portfolios and Specifications
Table 189. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 190. Sinovac Main Business
Table 191. Sinovac Latest Developments
LIST OF FIGURES
Figure 1. Picture of Streptococcus Pneumoniae Vaccine
Figure 2. Streptococcus Pneumoniae Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Streptococcus Pneumoniae Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Streptococcus Pneumoniae Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Streptococcus Pneumoniae Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 7 -Valent
Figure 10. Product Picture of 10 -Valent
Figure 11. Product Picture of 13 -Valent
Figure 12. Product Picture of 15 -Valent
Figure 13. Product Picture of 23 -Valent
Figure 14. Product Picture of Other
Figure 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2022
Figure 16. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2018-2023)
Figure 17. Streptococcus Pneumoniae Vaccine Consumed in Children under 2 Years of Age
Figure 18. Global Streptococcus Pneumoniae Vaccine Market: Children under 2 Years of Age (2018-2023) & (K Units)
Figure 19. Streptococcus Pneumoniae Vaccine Consumed in Adults over 65 Years of Age
Figure 20. Global Streptococcus Pneumoniae Vaccine Market: Adults over 65 Years of Age (2018-2023) & (K Units)
Figure 21. Streptococcus Pneumoniae Vaccine Consumed in Addicted Smokers Between the Ages of 19 and 64
Figure 22. Global Streptococcus Pneumoniae Vaccine Market: Addicted Smokers Between the Ages of 19 and 64 (2018-2023) & (K Units)
Figure 23. Streptococcus Pneumoniae Vaccine Consumed in Other
Figure 24. Global Streptococcus Pneumoniae Vaccine Market: Other (2018-2023) & (K Units)
Figure 25. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2022)
Figure 26. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application in 2022
Figure 27. Streptococcus Pneumoniae Vaccine Sales Market by Company in 2022 (K Units)
Figure 28. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company in 2022
Figure 29. Streptococcus Pneumoniae Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company in 2022
Figure 31. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Streptococcus Pneumoniae Vaccine Sales 2018-2023 (K Units)
Figure 34. Americas Streptococcus Pneumoniae Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. APAC Streptococcus Pneumoniae Vaccine Sales 2018-2023 (K Units)
Figure 36. APAC Streptococcus Pneumoniae Vaccine Revenue 2018-2023 ($ Millions)
Figure 37. Europe Streptococcus Pneumoniae Vaccine Sales 2018-2023 (K Units)
Figure 38. Europe Streptococcus Pneumoniae Vaccine Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue 2018-2023 ($ Millions)
Figure 41. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2022
Figure 42. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2022
Figure 43. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Figure 44. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Figure 45. United States Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region in 2022
Figure 50. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Regions in 2022
Figure 51. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Figure 52. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Figure 53. China Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2022
Figure 61. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2022
Figure 62. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Figure 63. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Figure 64. Germany Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Figure 73. Egypt Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine in 2022
Figure 79. Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
Figure 80. Industry Chain Structure of Streptococcus Pneumoniae Vaccine
Figure 81. Channels of Distribution
Figure 82. Global Streptococcus Pneumoniae Vaccine Sales Market Forecast by Region (2024-2029)
Figure 83. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Streptococcus Pneumoniae Vaccine
Figure 2. Streptococcus Pneumoniae Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Streptococcus Pneumoniae Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Streptococcus Pneumoniae Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Streptococcus Pneumoniae Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 7 -Valent
Figure 10. Product Picture of 10 -Valent
Figure 11. Product Picture of 13 -Valent
Figure 12. Product Picture of 15 -Valent
Figure 13. Product Picture of 23 -Valent
Figure 14. Product Picture of Other
Figure 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2022
Figure 16. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2018-2023)
Figure 17. Streptococcus Pneumoniae Vaccine Consumed in Children under 2 Years of Age
Figure 18. Global Streptococcus Pneumoniae Vaccine Market: Children under 2 Years of Age (2018-2023) & (K Units)
Figure 19. Streptococcus Pneumoniae Vaccine Consumed in Adults over 65 Years of Age
Figure 20. Global Streptococcus Pneumoniae Vaccine Market: Adults over 65 Years of Age (2018-2023) & (K Units)
Figure 21. Streptococcus Pneumoniae Vaccine Consumed in Addicted Smokers Between the Ages of 19 and 64
Figure 22. Global Streptococcus Pneumoniae Vaccine Market: Addicted Smokers Between the Ages of 19 and 64 (2018-2023) & (K Units)
Figure 23. Streptococcus Pneumoniae Vaccine Consumed in Other
Figure 24. Global Streptococcus Pneumoniae Vaccine Market: Other (2018-2023) & (K Units)
Figure 25. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2022)
Figure 26. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application in 2022
Figure 27. Streptococcus Pneumoniae Vaccine Sales Market by Company in 2022 (K Units)
Figure 28. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company in 2022
Figure 29. Streptococcus Pneumoniae Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company in 2022
Figure 31. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Streptococcus Pneumoniae Vaccine Sales 2018-2023 (K Units)
Figure 34. Americas Streptococcus Pneumoniae Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. APAC Streptococcus Pneumoniae Vaccine Sales 2018-2023 (K Units)
Figure 36. APAC Streptococcus Pneumoniae Vaccine Revenue 2018-2023 ($ Millions)
Figure 37. Europe Streptococcus Pneumoniae Vaccine Sales 2018-2023 (K Units)
Figure 38. Europe Streptococcus Pneumoniae Vaccine Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue 2018-2023 ($ Millions)
Figure 41. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2022
Figure 42. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2022
Figure 43. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Figure 44. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Figure 45. United States Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region in 2022
Figure 50. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Regions in 2022
Figure 51. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Figure 52. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Figure 53. China Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2022
Figure 61. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2022
Figure 62. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Figure 63. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Figure 64. Germany Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2018-2023)
Figure 73. Egypt Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Streptococcus Pneumoniae Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine in 2022
Figure 79. Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
Figure 80. Industry Chain Structure of Streptococcus Pneumoniae Vaccine
Figure 81. Channels of Distribution
Figure 82. Global Streptococcus Pneumoniae Vaccine Sales Market Forecast by Region (2024-2029)
Figure 83. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Application (2024-2029)
